Suzanne G. Mays

Enigmol: A Novel Sphingolipid Analogue with Anticancer Activity against Cancer Cell Lines and <i>In vivo</i> Models for Intestinal and Prostate Cancer

Holly Symolon, Anatoliy Bushnev, Qiong Peng et al. · Molecular Cancer Therapeutics · 2011 · 61 citations · Full text

Chemoprevention Strategy, Cancer Biology, Tumor Biology +20

Novel Synthesis and Biological Evaluation of Enigmols as Therapeutic Agents for Treating Prostate Cancer

Ethel C. Garnier‐Amblard, Suzanne G. Mays, Richard F. Arrendale et al. · ACS Medicinal Chemistry Letters · 2011 · 33 citations

Crystal Structures of the Nuclear Receptor, Liver Receptor Homolog 1, Bound to Synthetic Agonists

Suzanne G. Mays, C. Denise Okafor, Richard J. Whitby et al. · Journal of Biological Chemistry · 2016 · 32 citations · Full text

Molecular Biology, Molecular Pharmacology, Signaling Pathway +21

Development of the First Low Nanomolar Liver Receptor Homolog-1 Agonist through Structure-guided Design

Suzanne G. Mays, Autumn R. Flynn, Jeffery L. Cornelison et al. · Journal of Medicinal Chemistry · 2019 · 31 citations · Full text

Engineering, Biomedical Engineering, Nanomedicine +17

Atomic-Level Mechanism of Pre-mRNA Splicing in Health and Disease

Jure Borišek, Lorenzo Casalino, Andrea Saltalamacchia et al. · Accounts of Chemical Research · 2020 · 29 citations